
Symptom Research
Neuroimmunology Laboratories
Robert Dantzer, Ph.D. | Peter Grace, Ph.D. | Yuan Pan, Ph.D. | Andrew J. Shepherd, Ph.D.
Principal Investigators
- Departments, Labs and Institutes
- Labs
- Neuroimmunology Laboratories
Areas of Research
- Chemotherapy-Induced Neuropathy
- Chemotherapy-Induced Cognitive Impairments
- Chronic Pain
- Fatigue
- Depression
- Neuron-glia Interactions
The Neuroimmunology Laboratories are led by four well-funded, collaborative principal investigators who share space, equipment, and ideas in a highly interactive, international, research-focused environment. The overall aim of these laboratories is to increase our understanding of the pathophysiology of cancer therapy-induced neurobehavioral toxicities, including neuropathic pain, depressed mood, cognitive dysfunction, and fatigue. This newly acquired knowledge can then be applied to the rational design of novel interventions for alleviating symptom burden in patients with cancer.

Please join us for the next Neurobiology Seminar Series lecture
Peripheral and Central Mechanisms of Chronic Pain
Speaker: Arkady Khoutorsky, Ph.D., D.V.M.
Associate Professor, Departments of Anesthesia, Dental Medicine, and Oral Health Services
McGill University
April 4, 2025 ● 11:00 am - 12:00 pm CDT
Zayed Building, Z8.1003
Or join us on Zoom
Meeting ID: 833 2784 2321 ● Password: 425172
The Neuroimmunology Laboratories
Pain Research Symposium
ADVANCEMENTS IN TRANSLATIONAL SCIENCE FOR PAIN MANAGEMENT IN CANCER CARE: This symposium will connect you with MD Anderson clinical and basic science experts dedicated to ending pain for cancer patients and survivors. Engage in poster sessions, talks, and patient-caregiver panels to exchange insights and foster collaboration.
May 9, 2025 – Learn More and Register Opens a new windowDid You Know?
The Neuroimmunology Laboratories are part of the Department of Symptom Research.
The labs extend the department's ongoing descriptive research and interventional trials by incorporating animal models of pain, fatigue, neuropathy, cognitive impairment, and the underlying neuroinflammatory mechanisms.